Source: Annual Congress 2006 - Immunology of the airways
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kändler, K. Rüttger, R. Bals (Marburg, Germany). The antimicrobial peptide CRAMP is a regulator of inflammation during pneumonia. Eur Respir J 2006; 28: Suppl. 50, 1680

Member's Comments

No comment yet.

Related content which might interest you: Involvement of lymphocytes in mycoplasma pneumoniae pneumonia is associated with elevation in KC, IL-6 and TNF-α levels in bronchoalveolar lavage fluid Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens Year: 2007 Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006 Mycolic acid from mycobacterium tuberculosis suppresses experimental asthma by triggering the local induction of regulatory T cells Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006 Cellular changes in BAL fluid may reflect immunity in patients with lung cancer Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression Year: 2005 Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Inflammatory response to infectious pulmonary injury Source: Eur Respir J 2003; 22: 10S-14S Year: 2003 MTB-specific lymphocytes are selectively recruited to the site of infection in active pulmonary tuberculosis Source: Annual Congress 2007 - Immunology and genetics of tuberculosis Year: 2007 Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia Source: Eur Respir J 2009; 33: 375-381 Year: 2009 Blood and BAL T cell cytokine production during RV16 infection in normal and asthmatic human volunteers Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Airway inflammation: assessment of neutrophil apoptosis in induced sputum Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Impact of Pseudomonas aeruginosa infection on Na+ transport in airway epithelia Source: Annual Congress 2007 - The impact of viral and bacterial infection on the respiratory epithelium Year: 2007 Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia Source: Eur Respir J 2011; 38: 1158-1164 Year: 2011 The impact of time on the systemic inflammatory response in pneumococcal pneumonia Source: Eur Respir J 2010; 35: 614-618 Year: 2010 Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue Source: Eur Respir J 2012; 40: 1458-1467 Year: 2012 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Bronchial inflammatory changes in wheezy infants Source: Annual Congress 2007 - Bronchial inflammation in wheezing infants and pre-school children Year: 2007 Endogenous mediators of resolution Source: Annual Congress 2006 - Resolution of airway and tissue inflammation “ emerging concepts Year: 2006 Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells Source: Eur Respir J 2011; 37: 53-64 Year: 2011 Neomacrolides in airway disease Source: Annual Congress 2005 - New developments in infectious disease Year: 2005